Health Care: Drugs

Halozyme Therapeutics Inc. (HALO: NASDAQ)

$7.96 -0.02 | -0.25%
05/17/13 - 04:00 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 42.33M 56.09M 13.62M 13.67M
Cost of Sales 14.98K 257.83K 985.28K -1.13M
Gross Operating Profit 42.31M 55.83M 12.64M 14.80M
Selling, General, and Administrative Expenses 24.81M 18.10M 15.12M 15.20M
Research & Development 70.04M 57.56M 51.77M 56.61M
Operating Income before D & A (EBITDA) -52.55M -19.84M -54.26M -57.01M
Depreciation & Amortization 1.08M 1.10M 1.51M 1.44M
Interest Income 59.03K 63.53K 49.02K 97.74K
Other Income - Net 14.42K 5.56K 966.97K 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -53.55M -20.87M -54.75M -58.36M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -53.55M -20.87M -54.75M -58.36M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -53.55M -19.77M -53.24M -58.36M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -53.55M -19.77M -53.24M -58.36M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -53.55M -19.77M -53.24M -58.36M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 -53.55M -19.77M -53.24M -58.36M
Preferred Dividends
Net Income Available To Common -53.55M -19.77M -53.24M -58.36M
Basic EPS from Continuing Ops. -0.48 -0.19 -0.56 -0.67
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.48 -0.19 -0.56 -0.67
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.48 -0.19 -0.56 -0.67
Basic Normalized Net Income/Share -0.48 -0.19 -0.56 -0.67
EPS fr Continuing Ops. -0.48 -0.19 -0.56 -0.67
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.48 -0.19 -0.56 -0.67
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.48 -0.19 -0.56 -0.67
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 -0.48 -0.19 -0.56 -0.67
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with HALO

View All

Latest HALO Headlines from TheStreet

More Financial News for HALO

Press Releases for HALO

See All Press Releases

Partner Headlines for HALO

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter